▲ 2.41%
prev close
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis, which has been further strengthened with the launch of new drugs in blood cancers (Blincyto) and solid tumors (Imdelltra). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Congressional Trades
30
All tracked trades
Members Trading
19
Unique members
Net Activity
+0
15 buys · 15 sells
Members Who Traded This Stock
30 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2026-09-22 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 19d ago | — | |
| 2026-08-26 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 45d ago | — | |
| 2026-08-26 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 45d ago | — | |
| 2026-06-05 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 130d ago | — | |
| 2026-04-17 | AMGNAmgen Inc | Sell | $15,001 - $50,000 | 165d ago | — | |
| 2026-03-24 | AMGNAmgen Inc | Buy | $15,001 - $50,000 | 182d ago | — | |
| 2026-02-26 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 228d ago | — | |
| 2026-01-29 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 260d ago | — | |
| 2026-01-16 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 260d ago | — | |
| 2025-12-03 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 319d ago | — | |
| 2025-10-24 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 357d ago | — | |
| 2025-09-25 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 363d ago | — | |
| 2025-09-04 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 382d ago | — | |
| 2025-04-15 | AMGNAmgen Inc | Sell | $15,001 - $50,000 | 523d ago | — | |
| 2025-04-08 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 530d ago | — | |
| 2025-02-24 | AMGNAmgen Inc | Buy | $15,001 - $50,000 | 590d ago | — | |
| 2025-02-11 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 426d ago | — | |
| 2024-12-06 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 652d ago | — | |
| 2024-11-19 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 280d ago | — | |
| 2024-10-23 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 280d ago | — | |
| 2024-08-07 | AMGNAmgen Inc | Buy | $50,001 - $100,000 | 791d ago | — | |
| 2024-08-07 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 474d ago | — | |
| 2024-01-02 | AMGNAmgen Inc | Sell | $15,001 - $50,000 | 1002d ago | — | |
| 2023-10-24 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 1076d ago | — | |
| 2023-03-06 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 1279d ago | — | |
| 2022-10-19 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 1440d ago | — | |
| 2022-09-26 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 1476d ago | — | |
| 2022-05-11 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 1587d ago | — | |
| 2021-03-04 | AMGNAmgen Inc | Buy | $15,001 - $50,000 | 1509d ago | — | |
| 2019-09-27 | AMGNAmgen Inc | Buy | $15,001 - $50,000 | 1167d ago | — |
2026-09-22
David J. Taylor
AMGN
Amount
$1,001 - $15,000
Filed
19d ago
2026-08-26
David J. Taylor
AMGN
Amount
$1,001 - $15,000
Filed
45d ago
2026-08-26
David J. Taylor
AMGN
Amount
$1,001 - $15,000
Filed
45d ago
2026-06-05
David J. Taylor
AMGN
Amount
$1,001 - $15,000
Filed
130d ago
2026-04-17
Maria Elvira Salazar
AMGN
Amount
$15,001 - $50,000
Filed
165d ago
2026-03-24
Maria Elvira Salazar
AMGN
Amount
$15,001 - $50,000
Filed
182d ago
2026-02-26
David J. Taylor
AMGN
Amount
$1,001 - $15,000
Filed
228d ago
2026-01-29
David J. Taylor
AMGN
Amount
$1,001 - $15,000
Filed
260d ago
2026-01-16
David J. Taylor
AMGN
Amount
$1,001 - $15,000
Filed
260d ago
2025-12-03
David J. Taylor
AMGN
Amount
$1,001 - $15,000
Filed
319d ago
2025-10-24
Marjorie Taylor Greene
AMGN
Amount
$1,001 - $15,000
Filed
357d ago
2025-09-25
Lisa McClain
AMGN
Amount
$1,001 - $15,000
Filed
363d ago
2025-09-04
Sheldon Whitehouse
AMGN
Amount
$1,001 - $15,000
Filed
382d ago
2025-04-15
Tommy Tuberville
AMGN
Amount
$15,001 - $50,000
Filed
523d ago
2025-04-08
Rob Bresnahan
AMGN
Amount
$1,001 - $15,000
Filed
530d ago
2025-02-24
Jefferson Shreve
AMGN
Amount
$15,001 - $50,000
Filed
590d ago
2025-02-11
Daniel Meuser
AMGN
Amount
$1,001 - $15,000
Filed
426d ago
2024-12-06
Virginia Foxx
AMGN
Amount
$1,001 - $15,000
Filed
652d ago
2024-11-19
Julia Letlow
AMGN
Amount
$1,001 - $15,000
Filed
280d ago
2024-10-23
Julia Letlow
AMGN
Amount
$1,001 - $15,000
Filed
280d ago
2024-08-07
C. Scott Franklin
AMGN
Amount
$50,001 - $100,000
Filed
791d ago
2024-08-07
Scott Scott Franklin
AMGN
Amount
$1,001 - $15,000
Filed
474d ago
2024-01-02
Michael C. Burgess
AMGN
Amount
$15,001 - $50,000
Filed
1002d ago
2023-10-24
Greg Stanton
AMGN
Amount
$1,001 - $15,000
Filed
1076d ago
2023-03-06
Josh Gottheimer
AMGN
Amount
$1,001 - $15,000
Filed
1279d ago
2022-10-19
Josh Gottheimer
AMGN
Amount
$1,001 - $15,000
Filed
1440d ago
2022-09-26
Earl Blumenauer
AMGN
Amount
$1,001 - $15,000
Filed
1476d ago
2022-05-11
Josh Gottheimer
AMGN
Amount
$1,001 - $15,000
Filed
1587d ago
2021-03-04
Carol Devine Miller
AMGN
Amount
$15,001 - $50,000
Filed
1509d ago
2019-09-27
Richard W. Allen
AMGN
Amount
$15,001 - $50,000
Filed
1167d ago
Recent News
Powered by Polygon.io
Migraine Market is Expected to Expand at 6% Growth Rate by 2036, Owing to the Development of Novel Mechanisms beyond CGRP, including PACAP-targeted Therapies, TRPA1 Antagonists, and Next-generation Neuromuscular Approaches | DelveInsight
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Beat the Market the Zacks Way: Valero Energy, Hagerty, Palantir in Focus
Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider
Can RARE's Approved Product Portfolio Drive Its Next Growth Phase?
Trade Timeline
Congressional activity, newest first
David J. Taylor
2026-09-22 · Purchase
$1,001 - $15,000
David J. Taylor
2026-08-26 · Sale
$1,001 - $15,000
David J. Taylor
2026-08-26 · Sale
$1,001 - $15,000
David J. Taylor
2026-06-05 · Purchase
$1,001 - $15,000
Maria Elvira Salazar
2026-04-17 · Sale
$15,001 - $50,000
Maria Elvira Salazar
2026-03-24 · Purchase
$15,001 - $50,000
David J. Taylor
2026-02-26 · Sale
$1,001 - $15,000
David J. Taylor
2026-01-29 · Sale
$1,001 - $15,000
David J. Taylor
2026-01-16 · Purchase
$1,001 - $15,000
David J. Taylor
2025-12-03 · Sale
$1,001 - $15,000
Marjorie Taylor Greene
2025-10-24 · Purchase
$1,001 - $15,000
Lisa McClain
2025-09-25 · Sale
$1,001 - $15,000
Sheldon Whitehouse
2025-09-04 · Sale
$1,001 - $15,000
Tommy Tuberville
2025-04-15 · Sale
$15,001 - $50,000
Rob Bresnahan
2025-04-08 · Sale
$1,001 - $15,000
Jefferson Shreve
2025-02-24 · Purchase
$15,001 - $50,000
Daniel Meuser
2025-02-11 · Sale
$1,001 - $15,000
Virginia Foxx
2024-12-06 · Purchase
$1,001 - $15,000
Julia Letlow
2024-11-19 · Sale
$1,001 - $15,000
Julia Letlow
2024-10-23 · Purchase
$1,001 - $15,000
C. Scott Franklin
2024-08-07 · Purchase
$50,001 - $100,000
Scott Scott Franklin
2024-08-07 · Purchase
$1,001 - $15,000
Michael C. Burgess
2024-01-02 · Sale
$15,001 - $50,000
Greg Stanton
2023-10-24 · Sale
$1,001 - $15,000
Josh Gottheimer
2023-03-06 · Sale
$1,001 - $15,000
Josh Gottheimer
2022-10-19 · Purchase
$1,001 - $15,000
Earl Blumenauer
2022-09-26 · Purchase
$1,001 - $15,000
Josh Gottheimer
2022-05-11 · Purchase
$1,001 - $15,000
Carol Devine Miller
2021-03-04 · Purchase
$15,001 - $50,000
Richard W. Allen
2019-09-27 · Purchase
$15,001 - $50,000